191 related articles for article (PubMed ID: 17039986)
1. Methadone in the treatment of pain and terminal delirum in advanced cancer patients.
Moryl N; Kogan M; Comfort C; Obbens E
Palliat Support Care; 2005 Dec; 3(4):311-7. PubMed ID: 17039986
[TBL] [Abstract][Full Text] [Related]
2. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
[TBL] [Abstract][Full Text] [Related]
4. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
[TBL] [Abstract][Full Text] [Related]
5. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
Lawlor PG; Turner KS; Hanson J; Bruera ED
Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
[TBL] [Abstract][Full Text] [Related]
6. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
[TBL] [Abstract][Full Text] [Related]
7. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
9. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
[TBL] [Abstract][Full Text] [Related]
10. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
12. The role of methadone in opioid rotation-a Polish experience.
Leppert W
Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743
[TBL] [Abstract][Full Text] [Related]
13. Dose ratios between high dose oral morphine or equivalents and oral methadone.
Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
[TBL] [Abstract][Full Text] [Related]
14. Methadone titration in opioid-resistant cancer pain.
Scholes CF; Gonty N; Trotman IF
Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
[TBL] [Abstract][Full Text] [Related]
15. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
16. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.
Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E
Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613
[TBL] [Abstract][Full Text] [Related]
17. Agitated terminal delirium and association with partial opioid substitution and hydration.
Morita T; Tei Y; Inoue S
J Palliat Med; 2003 Aug; 6(4):557-63. PubMed ID: 14516497
[TBL] [Abstract][Full Text] [Related]
18. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population.
Tse DM; Sham MM; Ng DK; Ma HM
Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853
[TBL] [Abstract][Full Text] [Related]
19. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
Leng G; Finnegan MJ
Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
[TBL] [Abstract][Full Text] [Related]
20. Methadone for cancer pain: a case report.
Nixon AJ
Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
[No Abstract] [Full Text] [Related]
[Next] [New Search]